# Characterizing the Intraocular Scattering at Different Wavelengths

> **NCT05602623** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Vision, Ocular

## Interventions

- **DEVICE:** Adaptive Optics System (AO)

## Key facts

- **NCT ID:** NCT05602623
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-25
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-06-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05602623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05602623, "Characterizing the Intraocular Scattering at Different Wavelengths". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05602623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*